This is particularly true for breast cancer, as silencing of OPN not only inhibited cancer progression through downregulation of uPA, MMP-2, and MMP-9 expression levels [226] but also rendered these cells more sensitive to radiation-induced apoptosis and senescence [227] and enhanced their sensitivity to chemotherapeutic agents [228]. This evidence concerns the gene SPP1 and breast cancer.